This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Shigdar S, Luczo J, Wei MQ, Bell R, Danks A, Liu K, et al. Aptamer therapeutics: the 21st century’s magic bullet of nanomedicine. Open Conf Proc J 2010; 1: 118-24. 10.2174/22102892010010100118ShigdarSLuczoJWeiMQBellRDanksALiuKAptamer therapeutics: the 21st century’s magic bullet of nanomedicineOpen Conf Proc J201011182410.2174/22102892010010100118Open DOISearch in Google Scholar
Baird GS. Where are all the aptamers? Am J Clin Pathol 2010; 134: 529-31. 10.1309/AJCPFU4CG2WGJJKSBairdGS.Where are all the aptamers?Am J Clin Pathol20101345293110.1309/AJCPFU4CG2WGJJKSOpen DOISearch in Google Scholar
Šmuc T, Ahn IY, Ulrich H. Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics. J Pharm Biomed Anal 2013; 81-82: 210-7. 10.1016/j.jpba.2013.03.014ŠmucTAhnIYUlrichH.Nucleic acid aptamers as high affinity ligands in biotechnology and biosensoricsJ Pharm Biomed Anal201381-82210710.1016/j.jpba.2013.03.014Open DOISearch in Google Scholar
Zhou J, Rossi JJ. Cell-specific aptamer-mediated targeted drug delivery. Oligonucleotides 2011; 21: 1-10. 10.1089/oli.2010.0264ZhouJRossiJJ.Cell-specific aptamer-mediated targeted drug deliveryOligonucleotides20112111010.1089/oli.2010.0264Open DOISearch in Google Scholar
Ulrich H, Wrenger C. Disease-specific biomarker discovery by aptamers. Cytometry A 2009; 75: 727-33. 10.1002/cyto.a.20766UlrichHWrengerC.Disease-specific biomarker discovery by aptamersCytometryA2009757273310.1002/cyto.a.20766Open DOISearch in Google Scholar
Nery AA, Wrenger C, Ulrich H. Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agents. J Sep Sci 2009; 32: 1523-30. 10.1002/jssc.200800695NeryAAWrengerCUlrichH.Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agentsJ Sep Sci20093215233010.1002/jssc.200800695Open DOISearch in Google Scholar
Ni S, Yao H, Wang L, Lu J, Jiang F, Lu A, et al. Chemical modifications of nucleic acid aptamers for therapeutic purposes. Int J Mol Sci 2017; pii: E1683. 10.3390/ijms18081683.NiSYaoHWangLLuJJiangFLuAChemical modifications of nucleic acid aptamers for therapeutic purposesInt J Mol Sci2017pii: E168310.3390/ijms18081683Open DOISearch in Google Scholar
Ulrich H, Tárnok A. Flow cytometry detection of circulating tumor cells: achievements and limitations as prognostic parameters. Cytometry A 2014; 85: 201-2. 10.1002/cyto.a.22441UlrichHTárnokA.Flow cytometry detection of circulating tumor cells: achievements and limitations as prognostic parametersCytometry A201485201210.1002/cyto.a.22441Open DOISearch in Google Scholar
Krebs MG, Hou J-M, Sloane R, Lancashire L, Priest L, Nonaka D, et al. Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches. J Thorac Oncol [Internet]. 2012; 7: 306-15.KrebsMGHouJ-MSloaneRLancashireLPriestLNonakaDAnalysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent ApproachesJ Thorac Oncol [Internet]201273061510.1097/JTO.0b013e31823c5c16Search in Google Scholar
Zhao Z, Xu L, Shi X, Tan W, Shangguan D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst 2009; 134: 1808-14. 10.1039/B904476KZhaoZXuLShiXTanWShangguanD.Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cellsAnalyst200913418081410.1039/B904476KOpen DOISearch in Google Scholar
Jimenez E, Sefah K, Lopez-Colon D, Van Simaeys D, Chen HWi, Tockman MS, et al. Generation of lung adenocarcinoma DNA aptamers for cancer studies. PLoS One 2012; 7: 1-7. 10.1371/journal.pone.0046222JimenezESefahKLopez-ColonDVan SimaeysDChenHWiTockmanMSGeneration of lung adenocarcinoma DNA aptamers for cancer studiesPLoS One201271710.1371/journal.pone.0046222Open DOISearch in Google Scholar
Zamay GS, Kolovskaya OS, Zamay TN, Glazyrin YE, Krat AV, Zubkova O, et al. Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. Mol Ther 2015; 23: 1486-96. 10.1038/mt.2015.108ZamayGSKolovskayaOSZamayTNGlazyrinYEKratAVZubkovaOAptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human bloodMol Ther20152314869610.1038/mt.2015.108Open DOISearch in Google Scholar
Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, et al. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines. PLoS One 2013; 8: e57020. 10.1371/journal.pone.0057020WangPGaoQSuoZMuntheESolbergSMaLIdentification and characterization of cells with cancer stem cell properties in human primary lung cancer cell linesPLoS One20138e5702010.1371/journal.pone.0057020Open DOISearch in Google Scholar
Yan X, Luo H, Zhou X, Zhu B, Wang Y, Bian X. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines. Oncol Rep 2013; 30: 2733-40. 10.3892/or.2013.2784YanXLuoHZhouXZhuBWangYBianX.Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell linesOncol Rep20133027334010.3892/or.2013.2784Open DOISearch in Google Scholar
Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A.; 100: 15416-21. 10.1073/pnas.2136683100DanielsDAChenHHickeBJSwiderekKMGoldL.A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichmentProc Natl Acad Sci U S A.100154162110.1073/pnas.2136683100Open DOISearch in Google Scholar
Giordano RJ, Cardó-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat Med 2001; 7: 1249-53. 10.1038/nm1101-1249GiordanoRJCardó-VilaMLahdenrantaJPasqualiniRArapW.Biopanning and rapid analysis of selective interactive ligandsNat Med2001712495310.1038/nm1101-1249Open DOISearch in Google Scholar
Telez A, Rubinstein P. Rapid method for separation of blood cells. Transfusion 1970; 10: 223-5. 10.1111/j.1537-2995.1970.tb00733TelezARubinsteinP.Rapid method for separation of blood cellsTransfusion197010223510.1111/j.1537-2995.1970.tb00733Open DOISearch in Google Scholar
Nascimento IC, Nery AA, Bassaneze V, Krieger JE, Ulrich H. Applications of aptamers in flow and imaging cytometry. Methods Mol Biol 2016; 1380: 127-34. 10.1007/978-1-4939-3197-2_10NascimentoICNeryAABassanezeVKriegerJEUlrichH.Applications of aptamers in flow and imaging cytometryMethods Mol Biol201613801273410.1007/978-1-4939-3197-2_10Open DOISearch in Google Scholar
Bailey TL, Johnson J, Grant CE, Noble WS. The MEME suite. Nucleic Acids Res 2015; 43: W39-49. 10.1093/nar/gkv416BaileyTLJohnsonJGrantCENobleWS.The MEME suiteNucleic Acids Res201543W394910.1093/nar/gkv416Open DOISearch in Google Scholar
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013; 30: 2725-9. 10.1093/molbev/mst197TamuraKStecherGPetersonDFilipskiAKumarS.MEGA6: Molecular evolutionary genetics analysis version 6.0Mol Biol Evol2013302725910.1093/molbev/mst197Open DOISearch in Google Scholar
Markham NR, Zuker M. UNAFold: Software for nucleic acid folding and hybridization. Methods Mol Biol 2008; 453: 3-31. 10.1007/978-1-60327-429-6_1MarkhamNRZukerM.UNAFold: Software for nucleic acid folding and hybridizationMethods Mol Biol200845333110.1007/978-1-60327-429-6_1Open DOISearch in Google Scholar
Kinghorn AB, Fraser LA, Tanner JA. Aptamer bioinformatics. Int J Mol Sci 2017; pii: E2561. 10.3390/ijms18122516KinghornABFraserLATannerJA.Aptamer bioinformaticsInt J Mol Sci2017pii: E256110.3390/ijms18122516Open DOISearch in Google Scholar
Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, Toth IC, et al. Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations. Eur Respir J 2012; 39: 9-28. 10.1183/09031936.00190310BerghmansTPasleauFPaesmansMBonduelleYCadranelJTothICSurrogate markers predicting overall survival for lung cancer: ELCWP recommendationsEur Respir J20123992810.1183/09031936.00190310Open DOISearch in Google Scholar
Eberhard DA, Giaccone G, Johnson BE. Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer working group: standardization for use in the clinical trial setting. J Clin Oncol 2008; 26: 983-94. 10.1200/JCO.2007.12.9858EberhardDAGiacconeGJohnsonBE.Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer working group: standardization for use in the clinical trial settingJ Clin Oncol2008269839410.1200/JCO.2007.12.9858Open DOISearch in Google Scholar
